Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / Altitude Life Science Ventures Fund II, L.P.

Altitude Life Science Ventures Fund II, L.P.

UnknownUnknownFundADV: Venture Capital FundAltitude Ventures Management, LLCDelaware
Amounts, each with its basis
Vintage
unknownno dated first sale or first report yet
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$75.0Mwhat may be sold, not what was raised; file 021-238730, sworn by the adviser or filed under this vehicle
Form D sold
$0as of the filing of Apr 27, 2015
First sale
unknown
Reported GAV
$25.1Mon the Form ADV filed Mar 31, 2024; the fund's assets, never its size or dry powder
Owners (ADV)
2
Reported on ADV
Jun 29, 2015 to Mar 31, 2024
Fundraising evidence
Unknown
latest Form D 2015-04-27, older than 15 months (fr-1)
evidence dated Apr 27, 2015. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Unknown
no vintage and no recent Form D
first sale: n/avintage year: n/aadv gav as of: 2024-03-31vintage basis: n/aform d sold usd: 0form d offering usd: $75.0Mform d latest filed at: 2015-04-27
The fund's own reporting through time
11 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Jun 29, 2015Venture Capital Fund$50.0M
21%no
Jul 20, 2015Venture Capital Fund$50.0M
21%no
Jun 3, 2016Venture Capital Fund$14.3M
21%yes
Mar 31, 2017Venture Capital Fund$22.3M
21%yes
Mar 31, 2018Venture Capital Fund$46.6M
21%yes
Apr 5, 2019Venture Capital Fund$74.1M
21%yes
Apr 1, 2020Venture Capital Fund$71.4M
21%yes
Mar 30, 2021Venture Capital Fund$57.4M
21%yes
Mar 31, 2022Venture Capital Fund$67.2M
21%yes
Mar 31, 2023Venture Capital Fund$43.8M
21%yes
Mar 31, 2024Venture Capital Fund$25.1M
21%yes
Principals and agents
3 principals on Form D, 0 placement agents
  • Altitude Life Science Ventures II, LLC Director
  • Altitude Ventures Management, LLC Director
  • David Maki Director
Limited partners and their reported performance
1 public LP report
LPVintage (LP’s)CommittedPaid inDistributedRemaining valueNet IRRMultipleAs of
Alaska Permanent Fund Corporation apfc.org2015$50.0Mn/an/an/anot meaningful yetunknownDec 31, 2025

Each row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).

Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
3 events
  1. Dec 31, 2025
    APFC reports Altitude Life Science Ventures Fund II LP: $50,000,000 committed, vintage 2015
    LP commitment disclosed Fact Public pension and endowment private-markets disclosures (CalPERS, CalSTRS, WSIB, NYSCRF, Texas TRS, UTIMCO ...)
  2. Jun 29, 2015
    Altitude Life Science Ventures Fund II, L.P. first reported on Form ADV by Altitude Ventures Management, LLC (Venture Capital Fund), GAV $50,000,000
    Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Apr 27, 2015
    Altitude Life Science Ventures Fund II, L.P. filed Form D: no sales yet of $75,000,000, Venture Capital Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this vehicle